FDA Approves Idacio as Eighth Adalimumab Biosimilar in US FDA Approves Idacio as Eighth Adalimumab Biosimilar in US

Data for Idacio (adalimumab-aacf) showed safety, efficacy, and immunogenicity similar to Humira.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Alert Source Type: news